{
    "Participant": "hu6ED94A", 
    "Report URL": "http://evidence.pgp-hms.org/genomes?display_genome_id=8da41a77550b0e8be2042ff891449a8bce5c4746", 
    "Variants": [
        {
            "Allele Frequency": "?", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "High", 
            "Condition Tags": [
                "Anatomical and congenital"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "VPS13B", 
            "Impact": "Pathogenic", 
            "Inheritance": "Recessive", 
            "PMID Count": 1, 
            "PMID List": [
                "15141358"
            ], 
            "Scores": {
                "Case/Control": "0", 
                "Computational": null, 
                "Familial": "1", 
                "Functional": null, 
                "Penetrance": "5", 
                "Severity": "4", 
                "Treatability": "1"
            }, 
            "Status": "Heterozygous", 
            "Summary": "According to Kolehmainen, et al 2004 this was seen homozygously in a pair of siblings from a family with Cohen syndrome, in a screen of 76 patients from 59 families.", 
            "URL": "http://evidence.pgp-hms.org/VPS13B-N2968S", 
            "Variant Name": "VPS13B-N2968S", 
            "Variant Page": "http://evidence.pgp-hms.org/VPS13B-N2968S"
        }, 
        {
            "Allele Frequency": "0.061", 
            "Build 37 Chromosome": "chr1", 
            "Build 37 Position": "237778084", 
            "Build 37 Variant Allele": "A", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "High", 
            "Condition Tags": [
                "Heart and circulatory", 
                "Muscular, skeletal, and connective tissue", 
                "Nervous system"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "RYR2", 
            "Impact": "Pathogenic", 
            "Inheritance": "Recessive", 
            "PMID Count": 2, 
            "PMID List": [
                "16769042", 
                "18326664"
            ], 
            "Scores": {
                "Case/Control": "2", 
                "Computational": "1", 
                "Familial": "0", 
                "Functional": "1", 
                "Penetrance": "4", 
                "Severity": "4", 
                "Treatability": "3"
            }, 
            "Status": "Heterozygous", 
            "Summary": "Reported to cause arrhythmogenic right ventricular cardiomyopathy when compound heterozygous with G1885E, although this finding is weakened after correcting for multiple hypotheses and it is unclear what penetrance such a genotype might have, if it is causal.", 
            "URL": "http://evidence.pgp-hms.org/RYR2-G1886S", 
            "Variant Name": "RYR2-G1886S", 
            "Variant Page": "http://evidence.pgp-hms.org/RYR2-G1886S", 
            "dbSNP IDs": [
                "rs3766871"
            ]
        }, 
        {
            "Allele Frequency": "0.027", 
            "Build 37 Chromosome": "chr7", 
            "Build 37 Position": "92132493", 
            "Build 37 Variant Allele": "C", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "High", 
            "Condition Tags": [
                "Metabolism"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "PEX1", 
            "Impact": "Pathogenic", 
            "Inheritance": "Recessive", 
            "PMID Count": 1, 
            "PMID List": [
                "11389485"
            ], 
            "Scores": {
                "Case/Control": "0", 
                "Computational": "-1", 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": "5", 
                "Severity": "5", 
                "Treatability": "1"
            }, 
            "Status": "Heterozygous", 
            "Summary": "Reported as a mutation causing peroxisome biogenesis disorder in a single patient, presumably in a recessive manner.", 
            "URL": "http://evidence.pgp-hms.org/PEX1-I696M", 
            "Variant Name": "PEX1-I696M", 
            "Variant Page": "http://evidence.pgp-hms.org/PEX1-I696M", 
            "dbSNP IDs": [
                "rs35996821"
            ]
        }, 
        {
            "Allele Frequency": "0.32", 
            "Build 37 Chromosome": "chr13", 
            "Build 37 Position": "110818598", 
            "Build 37 Variant Allele": "G", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Heart and circulatory"
            ], 
            "Evidence": "Likely", 
            "Gene Symbol": "COL4A1", 
            "Impact": "Pathogenic", 
            "Inheritance": "Dominant", 
            "PMID Count": 3, 
            "PMID List": [
                "10334796", 
                "18077766", 
                "20031579"
            ], 
            "Scores": {
                "Case/Control": "5", 
                "Computational": "0", 
                "Familial": "0", 
                "Functional": null, 
                "Penetrance": "2", 
                "Severity": "4", 
                "Treatability": "4"
            }, 
            "Status": "Heterozygous", 
            "Summary": "This common variant has been associated with arterial stiffness and, in Japanese, a small increased risk of myocardial infarction (MI, a.k.a. heart attack). This last observation supported a dominant effect for this variant and, assuming a lifetime risk of 15% for MI, we estimate carriers have an additional risk of 0.5-3%.", 
            "URL": "http://evidence.pgp-hms.org/COL4A1-Q1334H", 
            "Variant Name": "COL4A1-Q1334H", 
            "Variant Page": "http://evidence.pgp-hms.org/COL4A1-Q1334H", 
            "dbSNP IDs": [
                "rs3742207"
            ]
        }, 
        {
            "Allele Frequency": "0.093", 
            "Build 37 Chromosome": "chr1", 
            "Build 37 Position": "115236057", 
            "Build 37 Variant Allele": "A", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Metabolism", 
                "Muscular, skeletal, and connective tissue"
            ], 
            "Evidence": "Likely", 
            "Gene Symbol": "AMPD1", 
            "Impact": "Pathogenic", 
            "Inheritance": "Recessive", 
            "PMID Count": 1, 
            "PMID List": [
                "1631143"
            ], 
            "Scores": {
                "Case/Control": "5", 
                "Computational": "2", 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": "4", 
                "Severity": "2", 
                "Treatability": "1"
            }, 
            "Status": "Heterozygous", 
            "Summary": "Causes Adenosine Deaminase Deficiency in a recessive manner. Most of the time individuals do not report symptoms, but when symptoms do exist they to be post-exercise symptoms of muscle weakness, muscle pain, and getting tired more quickly.", 
            "URL": "http://evidence.pgp-hms.org/AMPD1-Q12X", 
            "Variant Name": "AMPD1-Q12X", 
            "Variant Page": "http://evidence.pgp-hms.org/AMPD1-Q12X", 
            "dbSNP IDs": [
                "rs17602729"
            ]
        }, 
        {
            "Allele Frequency": "0.27", 
            "Build 37 Chromosome": "chr17", 
            "Build 37 Position": "12915009", 
            "Build 37 Variant Allele": "A", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Cancer", 
                "Genital and urinary"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "ELAC2", 
            "Impact": "Pathogenic", 
            "Inheritance": "Complex/Other", 
            "PMID Count": 4, 
            "PMID List": [
                "12384782", 
                "15368467", 
                "18767027", 
                "20231859"
            ], 
            "Scores": {
                "Case/Control": "3", 
                "Computational": "1", 
                "Familial": "0", 
                "Functional": null, 
                "Penetrance": "2", 
                "Severity": "2", 
                "Treatability": "0"
            }, 
            "Status": "Heterozygous", 
            "Summary": "Reported to be associated with increased susceptibility to prostate cancer, but later studies weaken the hypothesis. Xu et al.'s meta-analysis concludes that there is a small but significant increased risk (OR = 1.13). Assuming a lifetime risk of 16% for prostate cancer we calculate this leads to an increased risk of ~1.5% (17.5% total).", 
            "URL": "http://evidence.pgp-hms.org/ELAC2-S217L", 
            "Variant Name": "ELAC2-S217L", 
            "Variant Page": "http://evidence.pgp-hms.org/ELAC2-S217L", 
            "dbSNP IDs": [
                "rs4792311"
            ]
        }, 
        {
            "Allele Frequency": "0.11", 
            "Build 37 Chromosome": "chr11", 
            "Build 37 Position": "68201295", 
            "Build 37 Variant Allele": "T", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Muscular, skeletal, and connective tissue"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "LRP5", 
            "Impact": "Pathogenic", 
            "Inheritance": "Complex/Other", 
            "PMID Count": 3, 
            "PMID List": [
                "18455228", 
                "19148563", 
                "20953208"
            ], 
            "Scores": {
                "Case/Control": "3", 
                "Computational": "1", 
                "Familial": "0", 
                "Functional": null, 
                "Penetrance": "2", 
                "Severity": "2", 
                "Treatability": "4"
            }, 
            "Status": "Heterozygous", 
            "Summary": "In a study of a UK population this variant was associated with a small increased risk of osteoporosis and osteoporotic bone fractures, with each copy of the variant presumed to have an additive effect. A study in Chinese young men failed to find an association with peak bone density.\n\n \n", 
            "URL": "http://evidence.pgp-hms.org/LRP5-A1330V", 
            "Variant Name": "LRP5-A1330V", 
            "Variant Page": "http://evidence.pgp-hms.org/LRP5-A1330V", 
            "dbSNP IDs": [
                "rs3736228"
            ]
        }, 
        {
            "Allele Frequency": "0.28", 
            "Build 37 Chromosome": "chr1", 
            "Build 37 Position": "182554557", 
            "Build 37 Variant Allele": "T", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Cancer", 
                "Genital and urinary"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "RNASEL", 
            "Impact": "Pathogenic", 
            "Inheritance": "Complex/Other", 
            "PMID Count": 4, 
            "PMID List": [
                "11941539", 
                "12022038", 
                "12415269", 
                "17407163"
            ], 
            "Scores": {
                "Case/Control": "2", 
                "Computational": "1", 
                "Familial": "0", 
                "Functional": null, 
                "Penetrance": "2", 
                "Severity": "4", 
                "Treatability": "4"
            }, 
            "Status": "Heterozygous", 
            "Summary": "Associated with increased risk of prostate cancer in individuals who already have a family history of prostate cancer, but studies have been unable to replicate this finding in sporadic (non-familial) prostate cancer cases.", 
            "URL": "http://evidence.pgp-hms.org/RNASEL-R462Q", 
            "Variant Name": "RNASEL-R462Q", 
            "Variant Page": "http://evidence.pgp-hms.org/RNASEL-R462Q", 
            "dbSNP IDs": [
                "rs486907"
            ]
        }, 
        {
            "Allele Frequency": "0.86", 
            "Build 37 Chromosome": "chr2", 
            "Build 37 Position": "231050715", 
            "Build 37 Variant Allele": "G", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Immune system"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "SP110", 
            "Impact": "Pathogenic", 
            "Inheritance": "Unknown", 
            "PMID Count": 1, 
            "PMID List": [
                "16803959"
            ], 
            "Scores": {
                "Case/Control": "4", 
                "Computational": "0", 
                "Familial": "0", 
                "Functional": null, 
                "Penetrance": "1", 
                "Severity": "4", 
                "Treatability": "4"
            }, 
            "Status": "Homozygous", 
            "Summary": "This variant is associated with a slightly increased risk of tuberculosis. It is unclear whether it is itself causal, or in linkage disequilibrium with some other causal variant that has a stronger effect.", 
            "URL": "http://evidence.pgp-hms.org/SP110-L425S", 
            "Variant Name": "SP110-L425S", 
            "Variant Page": "http://evidence.pgp-hms.org/SP110-L425S", 
            "dbSNP IDs": [
                "rs3948464"
            ]
        }, 
        {
            "Allele Frequency": "0.63", 
            "Build 37 Chromosome": "chr17", 
            "Build 37 Position": "7579472", 
            "Build 37 Variant Allele": "C", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Cancer"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "TP53", 
            "Impact": "Pathogenic", 
            "Inheritance": "Unknown", 
            "PMID Count": 6, 
            "PMID List": [
                "1975675", 
                "9607760", 
                "15355915", 
                "19837266", 
                "20615891", 
                "22184967"
            ], 
            "Scores": {
                "Case/Control": "0", 
                "Computational": "3", 
                "Familial": null, 
                "Functional": "1", 
                "Penetrance": "0", 
                "Severity": "0", 
                "Treatability": "0"
            }, 
            "Status": "Heterozygous", 
            "Summary": "This is a common variant was first reported as a polymorphism. It has since had mixed associations with cancer: Storey et al. conclude a 7x *increased* risk of HPV cancer for homozygotes vs hets, but Jones et al. find a 1.98x *decreased* risk for colorectal cancer. This variant may have significant impact on particular cancers, but it is unclear what effect it has on the overall burden of cancer.", 
            "URL": "http://evidence.pgp-hms.org/TP53-P72R", 
            "Variant Name": "TP53-P72R", 
            "Variant Page": "http://evidence.pgp-hms.org/TP53-P72R", 
            "dbSNP IDs": [
                "rs1042522"
            ]
        }, 
        {
            "Allele Frequency": "0.2", 
            "Build 37 Chromosome": "chr15", 
            "Build 37 Position": "55722882", 
            "Build 37 Variant Allele": "A", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Mental and behavioral"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "DYX1C1", 
            "Impact": "Pathogenic", 
            "Inheritance": "Unknown", 
            "PMID Count": 1, 
            "PMID List": [
                "12954984"
            ], 
            "Scores": {
                "Case/Control": "2", 
                "Computational": null, 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": "3", 
                "Severity": "2", 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "One study reports this variant to be associated with dyslexia. The study group was relatively small and so the results did not have strong significance. If they are representative this variant is associated with a doubled risk for dyslexia, but it is unclear whether the effect would be additive, dominant, or recessive.", 
            "URL": "http://evidence.pgp-hms.org/DYX1C1-E417X", 
            "Variant Name": "DYX1C1-E417X", 
            "Variant Page": "http://evidence.pgp-hms.org/DYX1C1-E417X", 
            "dbSNP IDs": [
                "rs57809907"
            ]
        }, 
        {
            "Allele Frequency": "0.0098", 
            "Build 37 Chromosome": "chr6", 
            "Build 37 Position": "26091185", 
            "Build 37 Variant Allele": "T", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Blood"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "HFE", 
            "Impact": "Pathogenic", 
            "Inheritance": "Recessive", 
            "PMID Count": 2, 
            "PMID List": [
                "12377814", 
                "18036208"
            ], 
            "Scores": {
                "Case/Control": "2", 
                "Computational": "1", 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": "0", 
                "Severity": "2", 
                "Treatability": "3"
            }, 
            "Status": "Heterozygous", 
            "Summary": "A \"mild\" variant which may cause a very small increased risk of iron overload (hereditary hemachromatosis).", 
            "URL": "http://evidence.pgp-hms.org/HFE-S65C", 
            "Variant Name": "HFE-S65C", 
            "Variant Page": "http://evidence.pgp-hms.org/HFE-S65C"
        }, 
        {
            "Allele Frequency": "0.078", 
            "Build 37 Chromosome": "chr1", 
            "Build 37 Position": "98165091", 
            "Build 37 Variant Allele": "C", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "High", 
            "Condition Tags": [
                "Other"
            ], 
            "Evidence": "Likely", 
            "Gene Symbol": "DPYD", 
            "Impact": "Pharmacogenetic", 
            "Inheritance": "Unknown", 
            "PMID Count": 3, 
            "PMID List": [
                "11895907", 
                "14635116", 
                "19104657"
            ], 
            "Scores": {
                "Case/Control": "5", 
                "Computational": null, 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": "5", 
                "Severity": "3", 
                "Treatability": "4"
            }, 
            "Status": "Heterozygous", 
            "Summary": "Associated with DPYD deficiency and poor prognosis for chemotherapy w/ 5-flurorouracil. ", 
            "URL": "http://evidence.pgp-hms.org/DPYD-M166V", 
            "Variant Name": "DPYD-M166V", 
            "Variant Page": "http://evidence.pgp-hms.org/DPYD-M166V", 
            "dbSNP IDs": [
                "rs2297595"
            ]
        }, 
        {
            "Allele Frequency": "0.35", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Other"
            ], 
            "Evidence": "Uncertain", 
            "Impact": "Pharmacogenetic", 
            "Inheritance": "Unknown", 
            "PMID Count": 0, 
            "Scores": {
                "Case/Control": "0", 
                "Computational": "1", 
                "Familial": "0", 
                "Functional": "-1", 
                "Penetrance": "0", 
                "Severity": "1", 
                "Treatability": "0"
            }, 
            "Status": "Heterozygous", 
            "Summary": "rs1544410 is a Vitamin D Receptor (VDR) single nucleotide polymorphism. It is unlikely that it has functional significance because it is located in an intron (Liu et. al.), but it is in strong linkage disequilibrium with rs731236 (Dvornyk et al), which is located in an exon. ", 
            "URL": "http://evidence.pgp-hms.org/rs1544410", 
            "Variant Name": "rs1544410", 
            "Variant Page": "http://evidence.pgp-hms.org/rs1544410", 
            "dbSNP IDs": [
                "rs1544410"
            ]
        }, 
        {
            "Allele Frequency": "0.49", 
            "Build 37 Chromosome": "chr19", 
            "Build 37 Position": "49206674", 
            "Build 37 Variant Allele": "A", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Moderate", 
            "Condition Tags": [
                "Blood", 
                "Immune system"
            ], 
            "Evidence": "Well-established", 
            "Gene Symbol": "FUT2", 
            "Impact": "Protective", 
            "Inheritance": "Recessive", 
            "PMID Count": 5, 
            "PMID List": [
                "7876235", 
                "12692541", 
                "19625485", 
                "20031047", 
                "22025362"
            ], 
            "Scores": {
                "Case/Control": "4", 
                "Computational": "2", 
                "Familial": null, 
                "Functional": "2", 
                "Penetrance": "5", 
                "Severity": "2", 
                "Treatability": "3"
            }, 
            "Status": "Heterozygous", 
            "Summary": "This recessive protective variant confers resistance to norovirus (which causes stomach flu). 20% of Caucasians and Africans are homozygous for this variant and are \"non-secretors\": they do not express ABO blood type antigens in their saliva or mucosal surfaces. Most strains of norovirus bind to these antigens in the gut, and so this non-secretor status confers almost total resistantance to most types of norovirus. There are notable exceptions, some strains of norovirus bind a different target and are equally infectious for secretors and non-secretors.", 
            "URL": "http://evidence.pgp-hms.org/FUT2-W154X", 
            "Variant Name": "FUT2-W154X", 
            "Variant Page": "http://evidence.pgp-hms.org/FUT2-W154X", 
            "dbSNP IDs": [
                "rs601338"
            ]
        }, 
        {
            "Allele Frequency": "0.34", 
            "Build 37 Chromosome": "chr20", 
            "Build 37 Position": "4680251", 
            "Build 37 Variant Allele": "G", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Other"
            ], 
            "Evidence": "Well-established", 
            "Gene Symbol": "PRNP", 
            "Impact": "Protective", 
            "Inheritance": "Complex/Other", 
            "PMID Count": 2, 
            "PMID List": [
                "18236005", 
                "19081515"
            ], 
            "Scores": {
                "Case/Control": "5", 
                "Computational": "3", 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": "0", 
                "Severity": "4", 
                "Treatability": "1"
            }, 
            "Status": "Heterozygous", 
            "Summary": "This variant is associated with some protective effects for prion disease -- individuals homozygous for this variant are less susceptible to Creutzfeldt-Jakob, and Papua New Guinea individuals heterozygotes at this site are less susceptible to kuru.\n\n", 
            "URL": "http://evidence.pgp-hms.org/PRNP-M129V", 
            "Variant Name": "PRNP-M129V", 
            "Variant Page": "http://evidence.pgp-hms.org/PRNP-M129V", 
            "dbSNP IDs": [
                "rs1799990"
            ]
        }, 
        {
            "Allele Frequency": "0.3", 
            "Build 37 Chromosome": "chr18", 
            "Build 37 Position": "21140432", 
            "Build 37 Variant Allele": "C", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Metabolism"
            ], 
            "Evidence": "Likely", 
            "Gene Symbol": "NPC1", 
            "Impact": "Protective", 
            "Inheritance": "Complex/Other", 
            "PMID Count": 3, 
            "PMID List": [
                "19151714", 
                "19174833", 
                "19910939"
            ], 
            "Scores": {
                "Case/Control": "4", 
                "Computational": "2", 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": "2", 
                "Severity": "3", 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "This variant is associated with a reduced risk of obesity, with an additive effect of -0.084 BMI per allele (an average of 0.54 pounds less, per allele, in a 5'6\" individual).\n\n\n\n\n\n", 
            "URL": "http://evidence.pgp-hms.org/NPC1-H215R", 
            "Variant Name": "NPC1-H215R", 
            "Variant Page": "http://evidence.pgp-hms.org/NPC1-H215R", 
            "dbSNP IDs": [
                "rs1805081"
            ]
        }, 
        {
            "Allele Frequency": "0.068", 
            "Build 37 Chromosome": "chr2", 
            "Build 37 Position": "44065090", 
            "Build 37 Variant Allele": "A", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Blood", 
                "Metabolism"
            ], 
            "Evidence": "Likely", 
            "Gene Symbol": "ABCG5", 
            "Impact": "Protective", 
            "Inheritance": "Unknown", 
            "PMID Count": 1, 
            "PMID List": [
                "19060911"
            ], 
            "Scores": {
                "Case/Control": "4", 
                "Computational": "1", 
                "Familial": "0", 
                "Functional": null, 
                "Penetrance": "1", 
                "Severity": "2", 
                "Treatability": "4"
            }, 
            "Status": "Heterozygous", 
            "Summary": "This variant has a mild protective effect on blood cholesterol. It is associated with slightly lower total and LDL cholesterol levels.", 
            "URL": "http://evidence.pgp-hms.org/ABCG5-R50C", 
            "Variant Name": "ABCG5-R50C", 
            "Variant Page": "http://evidence.pgp-hms.org/ABCG5-R50C", 
            "dbSNP IDs": [
                "rs6756629"
            ]
        }, 
        {
            "Allele Frequency": "0.74", 
            "Build 37 Chromosome": "chr11", 
            "Build 37 Position": "17409572", 
            "Build 37 Variant Allele": "C", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Metabolism"
            ], 
            "Evidence": "Likely", 
            "Gene Symbol": "KCNJ11", 
            "Impact": "Protective", 
            "Inheritance": "Unknown", 
            "PMID Count": 3, 
            "PMID List": [
                "17463246", 
                "17463248", 
                "20054294"
            ], 
            "Scores": {
                "Case/Control": "5", 
                "Computational": "1", 
                "Familial": "0", 
                "Functional": null, 
                "Penetrance": "2", 
                "Severity": "3", 
                "Treatability": "4"
            }, 
            "Status": "Homozygous", 
            "Summary": "This variant is associated with decreased risk of type 2 diabetes. It is unclear whether this variant has additive effects, or acts in a dominant or recessive manner. Assuming diabetes has a lifetime risk of 36%, we estimate a decreased risk of around 1-2% per copy of this variant.", 
            "URL": "http://evidence.pgp-hms.org/KCNJ11-K23E", 
            "Variant Name": "KCNJ11-K23E", 
            "Variant Page": "http://evidence.pgp-hms.org/KCNJ11-K23E", 
            "dbSNP IDs": [
                "rs5219"
            ]
        }, 
        {
            "Allele Frequency": "0.22", 
            "Build 37 Chromosome": "chr1", 
            "Build 37 Position": "237048500", 
            "Build 37 Variant Allele": "G", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Cancer"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "MTR", 
            "Impact": "Protective", 
            "Inheritance": "Complex/Other", 
            "PMID Count": 4, 
            "PMID List": [
                "10498402", 
                "14744749", 
                "17417062", 
                "17855192"
            ], 
            "Scores": {
                "Case/Control": "2", 
                "Computational": "2", 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": "1", 
                "Severity": "4", 
                "Treatability": "3"
            }, 
            "Status": "Heterozygous", 
            "Summary": "This variant was weakly associated with a protective effect vs. colorectal cancer, but only in individuals with low alcohol consumption.\n\n\n", 
            "URL": "http://evidence.pgp-hms.org/MTR-D919G", 
            "Variant Name": "MTR-D919G", 
            "Variant Page": "http://evidence.pgp-hms.org/MTR-D919G", 
            "dbSNP IDs": [
                "rs1805087"
            ]
        }, 
        {
            "Allele Frequency": "0.23", 
            "Build 37 Chromosome": "chr13", 
            "Build 37 Position": "110435231", 
            "Build 37 Variant Allele": "T", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Other"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "IRS2", 
            "Impact": "Protective", 
            "Inheritance": "Unknown", 
            "PMID Count": 1, 
            "PMID List": [
                "19887537"
            ], 
            "Scores": {
                "Case/Control": "2", 
                "Computational": null, 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "a.k.a Gly1057Asp, insulin receptor substrate-2 IRS2. The rs1805097(G) allele is associated with the Gly, and the (A) allele with Asp. \nA longevity study concluded that rs1805097(A;A) individuals were about twice as likely to live over 85 y/o (odds ratio 2.03, CI:1.39-2.99, p = .0003). ", 
            "URL": "http://evidence.pgp-hms.org/IRS2-G1057D", 
            "Variant Name": "IRS2-G1057D", 
            "Variant Page": "http://evidence.pgp-hms.org/IRS2-G1057D", 
            "dbSNP IDs": [
                "rs1805097"
            ]
        }, 
        {
            "Allele Frequency": "0.2", 
            "Build 37 Chromosome": "chr11", 
            "Build 37 Position": "89017961", 
            "Build 37 Variant Allele": "A", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Hearing and vision"
            ], 
            "Evidence": "Well-established", 
            "Gene Symbol": "TYR", 
            "Impact": "Benign", 
            "Inheritance": "Complex/Other", 
            "PMID Count": 7, 
            "PMID List": [
                "1820207", 
                "7704033", 
                "11284711", 
                "18326704", 
                "18488027", 
                "18488028", 
                "19533789"
            ], 
            "Scores": {
                "Case/Control": "5", 
                "Computational": "1", 
                "Familial": null, 
                "Functional": "2", 
                "Penetrance": "0", 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Homozygous", 
            "Summary": "This is a frequent pigmentation polymorphism in Europeans that affects function of the Tyrosinase gene. It is associated with blue instead of green eyes and sun sensitivity. For the most part this variant is benign, but many individuals with ocular albinism (which affects only the eyes) carry this variant along with another more severe variant in the same gene.", 
            "URL": "http://evidence.pgp-hms.org/TYR-R402Q", 
            "Variant Name": "TYR-R402Q", 
            "Variant Page": "http://evidence.pgp-hms.org/TYR-R402Q", 
            "dbSNP IDs": [
                "rs1126809"
            ]
        }, 
        {
            "Allele Frequency": "0.0017", 
            "Build 37 Chromosome": "chr11", 
            "Build 37 Position": "76869378", 
            "Build 37 Variant Allele": "A", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Hearing and vision"
            ], 
            "Evidence": "Likely", 
            "Gene Symbol": "MYO7A", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 3, 
            "PMID List": [
                "8900236", 
                "16963483", 
                "18700726"
            ], 
            "Scores": {
                "Case/Control": "4", 
                "Computational": "0", 
                "Familial": "0", 
                "Functional": "2", 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "Weston, et al. 1996 reported seeing this on the same DNA strand with another variant in a couple cases of Usher Type I syndrome. That other variant was believed to cause disease in a recessive manner, while this variant was speculated to be coincidental observed. ExAC allele frequency data confirms that this variant is merely uncommon in Europeans (1 in 170 are carriers). If it were causal, it would be a well-established cause; the lack of such evidence in the literature confirms that the variant is not a \"Mendelian\" cause of Usher Type I syndrome.", 
            "URL": "http://evidence.pgp-hms.org/MYO7A-R302H", 
            "Variant Name": "MYO7A-R302H", 
            "Variant Page": "http://evidence.pgp-hms.org/MYO7A-R302H", 
            "dbSNP IDs": [
                "rs41298135"
            ]
        }, 
        {
            "Allele Frequency": "0.011", 
            "Build 37 Chromosome": "chr2", 
            "Build 37 Position": "47643457", 
            "Build 37 Variant Allele": "A", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Cancer"
            ], 
            "Evidence": "Likely", 
            "Gene Symbol": "MSH2", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 6, 
            "PMID List": [
                "8776590", 
                "10023327", 
                "10469597", 
                "11870161", 
                "12673796", 
                "18470917"
            ], 
            "Scores": {
                "Case/Control": "3", 
                "Computational": "0", 
                "Familial": null, 
                "Functional": "3", 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "Although other variants in this mismatch repair gene are associated with cancer, most publications dismiss this variant as a polymorphism (HapMap allele frequency of 1.6%).", 
            "URL": "http://evidence.pgp-hms.org/MSH2-G322D", 
            "Variant Name": "MSH2-G322D", 
            "Variant Page": "http://evidence.pgp-hms.org/MSH2-G322D", 
            "dbSNP IDs": [
                "rs4987188"
            ]
        }, 
        {
            "Allele Frequency": "?", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Nervous system"
            ], 
            "Evidence": "Likely", 
            "Gene Symbol": "NEFL", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 0, 
            "Scores": {
                "Case/Control": "5", 
                "Computational": null, 
                "Familial": "0", 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Homozygous", 
            "Summary": "Although a frameshift in this gene would be predicted to cause Charcot-Marie Neuropathy, this particular position appears to reflect a single base insertion error/mutation in the reference genome (in other words, normal individuals are always homozygous for a deletion at this position relative to reference). See chr8:24,811,060-24,811,080 annotations on UCSC.", 
            "URL": "http://evidence.pgp-hms.org/NEFL-S472Shift", 
            "Variant Name": "NEFL-S472Shift", 
            "Variant Page": "http://evidence.pgp-hms.org/NEFL-S472Shift", 
            "dbSNP IDs": [
                "rs11340767"
            ]
        }, 
        {
            "Allele Frequency": "0.27", 
            "Build 37 Chromosome": "chr1", 
            "Build 37 Position": "201052310", 
            "Build 37 Variant Allele": "T", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Other"
            ], 
            "Evidence": "Likely", 
            "Gene Symbol": "CACNA1S", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 0, 
            "Scores": {
                "Case/Control": "5", 
                "Computational": "1", 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "Common polymorphism", 
            "URL": "http://evidence.pgp-hms.org/CACNA1S-L458H", 
            "Variant Name": "CACNA1S-L458H", 
            "Variant Page": "http://evidence.pgp-hms.org/CACNA1S-L458H", 
            "dbSNP IDs": [
                "rs12742169"
            ]
        }, 
        {
            "Allele Frequency": "0.26", 
            "Build 37 Chromosome": "chr15", 
            "Build 37 Position": "74219546", 
            "Build 37 Variant Allele": "T", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Hearing and vision"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "LOXL1", 
            "Impact": "Benign", 
            "Inheritance": "Complex/Other", 
            "PMID Count": 3, 
            "PMID List": [
                "17690259", 
                "18450598", 
                "20142848"
            ], 
            "Scores": {
                "Case/Control": "0", 
                "Computational": "-1", 
                "Familial": null, 
                "Functional": "0", 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "Associated with exfoliative glaucoma & syndrome (XFG & XFS) in various populations, but with contradicting results (protective in Caucasians, pathogenic in Japanese). Based on this it seems the variation itself -- although it affects protein structure -- is not itself causing disease. Instead it is likely associated with other nearby causal variants. As such, it is evaluated as benign by GET-Evidence (which focuses on reporting causal variants). See detailed variant report for disease risk associations.", 
            "URL": "http://evidence.pgp-hms.org/LOXL1-R141L", 
            "Variant Name": "LOXL1-R141L", 
            "Variant Page": "http://evidence.pgp-hms.org/LOXL1-R141L", 
            "dbSNP IDs": [
                "rs1048661"
            ]
        }, 
        {
            "Allele Frequency": "?", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Other"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "RXFP2", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 0, 
            "Scores": {
                "Case/Control": "4", 
                "Computational": null, 
                "Familial": "0", 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "Reported to cause cryptorchidism, as recorded in ClinVar by OMIM (http://www.ncbi.nlm.nih.gov/clinvar/RCV000004376/). This assertion comes from Gorlov et al 2002 (PMID: 12217959) and Ferlin et al 2003 (PMID: 12970298). Gorlov et al found this variant in 1 of 61 patients and, according to OMIM, Ferlin et al found the variant in 4 of 87 patients. ExAC data reports this variant has an allele frequency of 0.7% in Europeans, and Ferlin et al's finding has weak significance for enrichment relative to this allele frequency (p = 0.037). Although cryptorchidism is common, so is this variant \u2013 1 in 70 Europeans are carriers: if it had this effect with high penetrance we would see highly significant enrichment in patients. Although the variant could potentially be a risk factor there is no strong evidence for making this assertion, and the hypothesized effect recorded in ClinVar (i.e. high penetrance) should be considered disproven.", 
            "URL": "http://evidence.pgp-hms.org/RXFP2-T222P", 
            "Variant Name": "RXFP2-T222P", 
            "Variant Page": "http://evidence.pgp-hms.org/RXFP2-T222P"
        }, 
        {
            "Allele Frequency": "0.048", 
            "Build 37 Chromosome": "chr11", 
            "Build 37 Position": "102988504", 
            "Build 37 Variant Allele": "T", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Other"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "DYNC2H1", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 0, 
            "Scores": {
                "Case/Control": "2", 
                "Computational": "-1", 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "Presumed benign.", 
            "URL": "http://evidence.pgp-hms.org/DYNC2H1-Q304L", 
            "Variant Name": "DYNC2H1-Q304L", 
            "Variant Page": "http://evidence.pgp-hms.org/DYNC2H1-Q304L", 
            "dbSNP IDs": [
                "rs12146610"
            ]
        }, 
        {
            "Allele Frequency": "0.0065", 
            "Build 37 Chromosome": "chr1", 
            "Build 37 Position": "152279975", 
            "Build 37 Variant Allele": "C", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Immune system", 
                "Skin"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "FLG", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 0, 
            "Scores": {
                "Case/Control": "0", 
                "Computational": "0", 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "Tentatively evaluated as benign. Other, much more severe null mutations cause increased susceptibility ichthyosis vulgaris, atopic eczema, and allergies.", 
            "URL": "http://evidence.pgp-hms.org/FLG-H2463D", 
            "Variant Name": "FLG-H2463D", 
            "Variant Page": "http://evidence.pgp-hms.org/FLG-H2463D", 
            "dbSNP IDs": [
                "rs113188294"
            ]
        }, 
        {
            "Allele Frequency": "0.026", 
            "Build 37 Chromosome": "chr6", 
            "Build 37 Position": "132206079", 
            "Build 37 Variant Allele": "T", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Heart and circulatory"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "ENPP1", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 2, 
            "PMID List": [
                "12881724", 
                "20137773"
            ], 
            "Scores": {
                "Case/Control": "1", 
                "Computational": null, 
                "Familial": "0", 
                "Functional": null, 
                "Penetrance": "0", 
                "Severity": "0", 
                "Treatability": "0"
            }, 
            "Status": "Heterozygous", 
            "Summary": "Tentatively classified as benign. Initially reported as a recessive cause of infantile arterial calcification, but with no statistical significance. Other variants have been implicated as causal in these cases this variant. 5% allele frequency in caucasians contradicts this variant as having any highly pathogenic effect.", 
            "URL": "http://evidence.pgp-hms.org/ENPP1-R774C", 
            "Variant Name": "ENPP1-R774C", 
            "Variant Page": "http://evidence.pgp-hms.org/ENPP1-R774C", 
            "dbSNP IDs": [
                "rs28933977"
            ]
        }, 
        {
            "Allele Frequency": "0.43", 
            "Build 37 Chromosome": "chr7", 
            "Build 37 Position": "141673345", 
            "Build 37 Variant Allele": "G", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Other"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "TAS2R38", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 3, 
            "PMID List": [
                "12595690", 
                "15883422", 
                "20675712"
            ], 
            "Scores": {
                "Case/Control": "5", 
                "Computational": "1", 
                "Familial": "5", 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "This variant is strongly associated with causing the \"taster\" phenotype of phenylthiocarbamine (PTC) in a dominant manner.", 
            "URL": "http://evidence.pgp-hms.org/TAS2R38-A49P", 
            "Variant Name": "TAS2R38-A49P", 
            "Variant Page": "http://evidence.pgp-hms.org/TAS2R38-A49P", 
            "dbSNP IDs": [
                "rs713598"
            ]
        }, 
        {
            "Allele Frequency": "0.22", 
            "Build 37 Chromosome": "chr12", 
            "Build 37 Position": "33021934", 
            "Build 37 Variant Allele": "G", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Other"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "PKP2", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 1, 
            "PMID List": [
                "19955750"
            ], 
            "Scores": {
                "Case/Control": "0", 
                "Computational": "1", 
                "Familial": "0", 
                "Functional": "0", 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "This variant is a benign polymorphism.  ", 
            "URL": "http://evidence.pgp-hms.org/PKP2-L366P", 
            "Variant Name": "PKP2-L366P", 
            "Variant Page": "http://evidence.pgp-hms.org/PKP2-L366P", 
            "dbSNP IDs": [
                "rs1046116"
            ]
        }, 
        {
            "Allele Frequency": "0.21", 
            "Build 37 Chromosome": "chr17", 
            "Build 37 Position": "7906519", 
            "Build 37 Variant Allele": "T", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Hearing and vision"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "GUCY2D", 
            "Impact": "Benign", 
            "Inheritance": "Recessive", 
            "PMID Count": 1, 
            "PMID List": [
                "8944027"
            ], 
            "Scores": {
                "Case/Control": "0", 
                "Computational": "1", 
                "Familial": "0", 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "One publication suggested that this variant possibly causes Leber's congenital amaurosis in a recessive manner, but the frequency data (36% in 1000 genomes) contradicts any significant pathogenic effect.", 
            "URL": "http://evidence.pgp-hms.org/GUCY2D-A52S", 
            "Variant Name": "GUCY2D-A52S", 
            "Variant Page": "http://evidence.pgp-hms.org/GUCY2D-A52S", 
            "dbSNP IDs": [
                "rs61749665"
            ]
        }, 
        {
            "Allele Frequency": "0.024", 
            "Build 37 Chromosome": "chr16", 
            "Build 37 Position": "23641461", 
            "Build 37 Variant Allele": "G", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Other"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "PALB2", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 1, 
            "PMID List": [
                "17200668"
            ], 
            "Scores": {
                "Case/Control": "4", 
                "Computational": "0", 
                "Familial": "0", 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "Probably benign.", 
            "URL": "http://evidence.pgp-hms.org/PALB2-E672Q", 
            "Variant Name": "PALB2-E672Q", 
            "Variant Page": "http://evidence.pgp-hms.org/PALB2-E672Q", 
            "dbSNP IDs": [
                "rs45532440"
            ]
        }, 
        {
            "Allele Frequency": "0.057", 
            "Build 37 Chromosome": "chr1", 
            "Build 37 Position": "171080080", 
            "Build 37 Variant Allele": "A", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Metabolism"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "FMO3", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 1, 
            "PMID List": [
                "9536088"
            ], 
            "Scores": {
                "Case/Control": "1", 
                "Computational": "2", 
                "Familial": "0", 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "This common variant (HapMap allele frequency of 9.2%) appears to have no functional effect. OMIM has recorded it as having been seen homozygously in an individual with Trimethylaminuria, but Treacy et al. 1998 conclude it is a polymorphism.", 
            "URL": "http://evidence.pgp-hms.org/FMO3-V257M", 
            "Variant Name": "FMO3-V257M", 
            "Variant Page": "http://evidence.pgp-hms.org/FMO3-V257M", 
            "dbSNP IDs": [
                "rs1736557"
            ]
        }, 
        {
            "Allele Frequency": "0.058", 
            "Build 37 Chromosome": "chr1", 
            "Build 37 Position": "169521853", 
            "Build 37 Variant Allele": "G", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Other"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "F5", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 1, 
            "PMID List": [
                "17284699"
            ], 
            "Scores": {
                "Case/Control": "0", 
                "Computational": "1", 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "Presumed benign. This variant is not particularly rare and has not been reported to cause disease.", 
            "URL": "http://evidence.pgp-hms.org/F5-M413T", 
            "Variant Name": "F5-M413T", 
            "Variant Page": "http://evidence.pgp-hms.org/F5-M413T", 
            "dbSNP IDs": [
                "rs6033"
            ]
        }, 
        {
            "Allele Frequency": "0.045", 
            "Build 37 Chromosome": "chr1", 
            "Build 37 Position": "169483561", 
            "Build 37 Variant Allele": "C", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Blood"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "F5", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 0, 
            "Scores": {
                "Case/Control": "0", 
                "Computational": "2", 
                "Familial": "0", 
                "Functional": "0", 
                "Penetrance": null, 
                "Severity": "0", 
                "Treatability": "0"
            }, 
            "Status": "Heterozygous", 
            "Summary": "Other mutations in this gene are associated with Factor 5 deficiency. There is no literature implicating this variant, however, and it is fairly common in the population (3.8% in HapMap), and so it is currently labeled as benign.", 
            "URL": "http://evidence.pgp-hms.org/F5-D2222G", 
            "Variant Name": "F5-D2222G", 
            "Variant Page": "http://evidence.pgp-hms.org/F5-D2222G", 
            "dbSNP IDs": [
                "rs6027"
            ]
        }, 
        {
            "Allele Frequency": "0.89", 
            "Build 37 Chromosome": "chr1", 
            "Build 37 Position": "55529187", 
            "Build 37 Variant Allele": "A", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Other"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "PCSK9", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 1, 
            "PMID List": [
                "19351729"
            ], 
            "Scores": {
                "Case/Control": "5", 
                "Computational": "3", 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Homozygous", 
            "Summary": "This variant is likely benign. ", 
            "URL": "http://evidence.pgp-hms.org/PCSK9-G670E", 
            "Variant Name": "PCSK9-G670E", 
            "Variant Page": "http://evidence.pgp-hms.org/PCSK9-G670E", 
            "dbSNP IDs": [
                "rs505151"
            ]
        }, 
        {
            "Allele Frequency": "0.094", 
            "Build 37 Chromosome": "chr1", 
            "Build 37 Position": "115231254", 
            "Build 37 Variant Allele": "A", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Other"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "AMPD1", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 1, 
            "PMID List": [
                "15173240"
            ], 
            "Scores": {
                "Case/Control": "0", 
                "Computational": "0", 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "Probably benign, ancestral to15173240 pathogenic Q12X mutation.", 
            "URL": "http://evidence.pgp-hms.org/AMPD1-P48L", 
            "Variant Name": "AMPD1-P48L", 
            "Variant Page": "http://evidence.pgp-hms.org/AMPD1-P48L", 
            "dbSNP IDs": [
                "rs61752479"
            ]
        }, 
        {
            "Allele Frequency": "0.69", 
            "Build 37 Chromosome": "chr5", 
            "Build 37 Position": "33951693", 
            "Build 37 Variant Allele": "G", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Cancer"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "SLC45A2", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 4, 
            "PMID List": [
                "15714523", 
                "17044855", 
                "18563784", 
                "18806926"
            ], 
            "Scores": {
                "Case/Control": "5", 
                "Computational": null, 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": "0", 
                "Treatability": "0"
            }, 
            "Status": "Homozygous", 
            "Summary": "Pigmentation allele for non-black hair, and consequently, possible increased susceptibility to malignant melanoma.", 
            "URL": "http://evidence.pgp-hms.org/SLC45A2-L374F", 
            "Variant Name": "SLC45A2-L374F", 
            "Variant Page": "http://evidence.pgp-hms.org/SLC45A2-L374F", 
            "dbSNP IDs": [
                "rs16891982"
            ]
        }, 
        {
            "Allele Frequency": "1.0", 
            "Build 37 Chromosome": "chr2", 
            "Build 37 Position": "21235475", 
            "Build 37 Variant Allele": "C", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Other"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "APOB", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 0, 
            "Scores": {
                "Case/Control": "5", 
                "Computational": "5", 
                "Familial": "0", 
                "Functional": "0", 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Homozygous", 
            "Summary": "This position is almost certainly an error in the HG18 reference sequence. ", 
            "URL": "http://evidence.pgp-hms.org/APOB-Y1422C", 
            "Variant Name": "APOB-Y1422C", 
            "Variant Page": "http://evidence.pgp-hms.org/APOB-Y1422C", 
            "dbSNP IDs": [
                "rs568413"
            ]
        }, 
        {
            "Allele Frequency": "0.35", 
            "Build 37 Chromosome": "chr8", 
            "Build 37 Position": "55539395", 
            "Build 37 Variant Allele": "T", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Metabolism"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "RP1", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 2, 
            "PMID List": [
                "12764676", 
                "19364639"
            ], 
            "Scores": {
                "Case/Control": "4", 
                "Computational": "-1", 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "Probably benign. One report linked this variant to high triglycerides, but a later paper found a nearby SNP with similar association and suggests that both findings are caused by linkage to an undiscovered causal variant.", 
            "URL": "http://evidence.pgp-hms.org/RP1-N985Y", 
            "Variant Name": "RP1-N985Y", 
            "Variant Page": "http://evidence.pgp-hms.org/RP1-N985Y", 
            "dbSNP IDs": [
                "rs2293869"
            ]
        }, 
        {
            "Allele Frequency": "0.3", 
            "Build 37 Chromosome": "chr9", 
            "Build 37 Position": "98209594", 
            "Build 37 Variant Allele": "A", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Other"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "PTCH1", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 1, 
            "PMID List": [
                "15712338"
            ], 
            "Scores": {
                "Case/Control": "5", 
                "Computational": "-1", 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "Common polymorphism, presumed benign.", 
            "URL": "http://evidence.pgp-hms.org/PTCH1-P1315L", 
            "Variant Name": "PTCH1-P1315L", 
            "Variant Page": "http://evidence.pgp-hms.org/PTCH1-P1315L", 
            "dbSNP IDs": [
                "rs357564"
            ]
        }, 
        {
            "Allele Frequency": "0.46", 
            "Build 37 Chromosome": "chr7", 
            "Build 37 Position": "141672604", 
            "Build 37 Variant Allele": "C", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Other"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "TAS2R38", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 2, 
            "PMID List": [
                "12595690", 
                "20675712"
            ], 
            "Scores": {
                "Case/Control": "2", 
                "Computational": "2", 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "This variant is associated with \"taster\" status of PTC, along with 49P and 262A. Due to linkage disequilibrium, the independent effects of positions 296 and 262 is unclear. The presence of 49P confers taster status in a dominant fashion, but in the absence of 49P, the presence of 262A/296V is still positively associated with tasting PTC.", 
            "URL": "http://evidence.pgp-hms.org/TAS2R38-I296V", 
            "Variant Name": "TAS2R38-I296V", 
            "Variant Page": "http://evidence.pgp-hms.org/TAS2R38-I296V", 
            "dbSNP IDs": [
                "rs10246939"
            ]
        }
    ]
}